EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
+6.49%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$907M
AUM Growth
+$907M
(+14%)
Cap. Flow
+$64M
Cap. Flow
% of AUM
7.06%
Top 10 Holdings %
Top 10 Hldgs %
99.88%
Holding
12
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$32M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$32M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P 500 ETF Trust
SPY
$658B
| $690M | 76.11% | 1,202,804 +55,825 | +5% | +$32M |
|
2
iShares MSCI India ETF
INDA
$9.17B
| $142M | 15.65% | 2,425,144 | – | – |
|
|
3
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $32M | 3.53% | +507,600 | New | +$32M |
|
4
Foghorn Therapeutics
FHTX
$286M
| $14.7M | 1.62% | 1,573,761 | – | – |
|
5
Oric Pharmaceuticals
ORIC
$994M
| $10.1M | 1.12% | 989,410 | – | – |
|
6
Alector
ALEC
$238M
| $6.09M | 0.67% | 1,307,858 | – | – |
|
7
PMV Pharmaceuticals
PMVP
$74.2M
| $3.92M | 0.43% | 2,627,643 | – | – |
|
|
ME
8
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $3.59M | 0.4% | 10,243,122 | – | – |
|
9
Tenaya Therapeutics
TNYA
$184M
| $1.96M | 0.22% | 1,015,705 | – | – |
|
10
RAPT Therapeutics
RAPT
$188M
| $1.32M | 0.15% | 657,899 | – | – |
|
11
Surrozen
SRZN
$104M
| $1.05M | 0.12% | 87,696 | – | – |
|
|
12
Surrozen, Inc. Warrant
SRZNW
$71.6K
| $1.76K | ﹤0.01% | 170,833 | – | – |
|